Venezuela exposure profile · HSIC · Health Care

Henry Schein (HSIC): Venezuela Exposure Check

Independent audit of Henry Schein's exposure to Venezuela — OFAC SDN matches, SEC filings, and Caracas Research news corpus.

No exposure on record

Henry Schein has no Venezuela exposure on the public record.

As of this scan, Henry Schein (NYSE/NASDAQ: HSIC) has no entries on the OFAC Venezuela SDN list, no Venezuela-related disclosures we have indexed in its recent SEC filings, and no Caracas-corpus news mentions. This is consistent with no operational, financial, or compliance exposure to Venezuela. Always re-verify against primary sources before relying on this as a compliance answer.

Ticker
HSIC
S&P 500 sector
Health Care
Headquarters
Melville, New York
OFAC matches
0
EDGAR filings
0
Last refreshed
2026-04-19

OFAC Venezuela SDN matches

No entry on the OFAC Venezuela SDN list contains Henry Schein as of the most recent OFAC scrape. Always re-verify with OFAC Sanctions Search before transacting.

SEC filings disclosing Venezuela items

We searched Henry Schein's SEC filings (10-K, 10-Q, 8-K, 20-F, 6-K) for the past two years and found no mention of Venezuela, PdVSA, CITGO, or Caracas. This is consistent with no material disclosed exposure. The full SEC full-text search is here: EDGAR full-text search for Henry Schein .

Federal Register & news corpus mentions

No Federal Register notice or analyzed news article in our corpus references Henry Schein in a Venezuela context. Search the live sanctions tracker or the daily briefing index for ad-hoc context.
Methodology. This page combines four signals: (1) a hand-curated map of S&P 500 Venezuela exposure maintained by Caracas Research analysts; (2) fuzzy substring matching against every Venezuela-program OFAC SDN designation (refreshed twice daily); (3) the SEC EDGAR full-text search across the company's 10-K, 10-Q, 8-K, 20-F, and 6-K filings for the past 24 months; (4) a scan of our own analyzed-news corpus and US Federal Register notices. Last refreshed 2026-04-19. This is not legal or compliance advice; always verify with primary sources and qualified sanctions counsel before transacting.

Useful tools